Nicosia Luca, Vitale Claudio, Cuccia Francesco, Figlia Vanessa, Giaj-Levra Niccolò, Mazzola Rosario, Ricchetti Francesco, Rigo Michele, Ruggieri Ruggero, Cavalleri Stefano, Alongi Filippo
Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Verona, Negrar, Italy.
Urology Division, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Negrar, Italy.
Cancer Manag Res. 2022 Sep 20;14:2839-2846. doi: 10.2147/CMAR.S357814. eCollection 2022.
To evaluate the impact of Ialuril soft Gels (HA) in reducing acute genito-urinary (GU) toxicity in patients treated with adjuvant or salvage radiotherapy for a prostate cancer relapse.
The data of 305 patients were retrospectively collected. One hundred and five patients underwent adjuvant radiotherapy (aRT), while 200 a salvage treatment (sRT). GU toxicity was evaluated according to CTCAE v5.0. Every patient received RT combined with HA.
Grade 1-2 GU toxicity during RT was represented by: urgency (36%), dysuria (23%), increased urinary frequency (12.1%), and urinary retention (11.8%). Nevertheless, the majority of symptoms were present at the baseline. Grade 3 severe toxicity was represented by 10 (3.2%) cases of incontinence and 3 (1%) cases of urgency. The incidence of any-grade RT-related GU toxicity was significantly higher in the aRT group than the salvage group (esRT + sRT) (83.8% versus 64.5%). When comparing the incidence of any-grade RT-related GU toxicity in the aRT, esRT, and sRT groups we observed a significant correlation favoring sRT, over esRT, and aRT.
Postoperative hypofractionated radiotherapy is safe and not correlated with increase of unexpected toxicity when administered with oral hyaluronic acid. A prospective study is necessary to confirm these results.
评估伊阿卢利软凝胶(HA)在降低接受前列腺癌复发辅助或挽救性放疗患者急性泌尿生殖系统(GU)毒性方面的影响。
回顾性收集305例患者的数据。105例患者接受辅助放疗(aRT),200例接受挽救性治疗(sRT)。根据CTCAE v5.0评估GU毒性。每位患者均接受放疗联合HA治疗。
放疗期间1-2级GU毒性表现为:尿急(36%)、尿痛(23%)、尿频增加(12.1%)和尿潴留(11.8%)。然而,大多数症状在基线时就已存在。3级严重毒性表现为10例(3.2%)尿失禁和3例(1%)尿急。辅助放疗组中任何级别的放疗相关GU毒性发生率显著高于挽救性治疗组(esRT + sRT)(83.8%对64.5%)。比较aRT、esRT和sRT组中任何级别的放疗相关GU毒性发生率时,我们观察到显著相关性,支持sRT优于esRT和aRT。
术后低分割放疗是安全的,与口服透明质酸联合使用时不会增加意外毒性。需要进行前瞻性研究以证实这些结果。